Participation of elderly gynecological cancer patients in clinical trials-Reference-Cited by-同舟云学术

Participation of elderly gynecological cancer patients in clinical trials

Published:2018-08-30 Issue:4 Volume:298 Page:797-804
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Prieske Katharina^ORCID,Trillsch Fabian,Oskay-Özcelik Gülten,Chekerov Radoslav,Bleich Christiane,Oliveira-Ferrer Leticia,Grimm Donata,Kuerti Sascha,Mueller Volkmar,Suling Anna,Schmalfeldt Barbara,Sehouli Jalid,Mahner Sven,Woelber Linn

Funder

Medac Oncology

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,General Medicine

Link

http://link.springer.com/article/10.1007/s00404-018-4886-2/fulltext.html

Reference27 articles.

1. Talarico L, Chen G, Pazdur R (2004) Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 22(22):4626–4631

2. Villella J, Chalas E (2005) Optimising treatment of elderly patients with ovarian cancer: improving their enrollment in clinical trials. Drugs Aging 22(2):95–100

3. Lara PN Jr et al (2005) Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 23(36):9282–9289

4. Mathews C et al (2009) Willingness of gynecologic cancer patients to participate in clinical trials. Gynecol Oncol 112(1):161–165

5. Comis RL et al (2003) Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21(5):830–835

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitators to cervical cancer screening in a minority, urban, underserved population;Gynecologic Oncology Reports;2024-02

2. Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia;Acta Haematologica;2023

3. Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer;Frontiers in Immunology;2021-08-24

4. How did we take care of our older cancer patients during the first COVID-19 wave? The French experience;Bulletin du Cancer;2021-06

5. FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issue;Expert Review of Gastroenterology & Hepatology;2021-04-05